Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.55M | 4.96M | 4.58M | 4.24M | 3.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.63M | 11.01M | 8.35M | 7.91M | 6.45M |
| Operating Income | -14.63M | -11.01M | -8.35M | -7.91M | -6.45M |
| Income Before Tax | -14.10M | -10.44M | -7.82M | -7.18M | -5.92M |
| Income Tax Expenses | 800.00 | 800.00 | 800.00 | 800.00 | 800.00 |
| Earnings from Continuing Operations | -14.10 | -10.44 | -7.82 | -7.19 | -5.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.10M | -10.44M | -7.82M | -7.19M | -5.92M |
| EBIT | -14.63M | -11.01M | -8.35M | -7.91M | -6.45M |
| EBITDA | -14.53M | -10.91M | -8.25M | -7.79M | -6.31M |
| EPS Basic | -1.69 | -1.34 | -1.15 | -1.35 | -1.33 |
| Normalized Basic EPS | -1.13 | -0.91 | -0.79 | -0.91 | -0.96 |
| EPS Diluted | -1.69 | -1.34 | -1.15 | -1.35 | -1.33 |
| Normalized Diluted EPS | -1.13 | -0.91 | -0.79 | -0.91 | -0.96 |
| Average Basic Shares Outstanding | 32.58M | 30.59M | 27.36M | 22.73M | 18.92M |
| Average Diluted Shares Outstanding | 32.58M | 30.59M | 27.36M | 22.73M | 18.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |